在纳米磁盘中评估A2AR的功能和稳定性的带结合动力学
John M Pettersen1, Olivia McCracken1, Anne Skaja Robinson1
1Department of Chemical Engineering, Carnegie Mellon University, Pittsburgh, Pennsylvania.
Biophysical journal
|December 18, 2024
概括
确定像腺素A2A受体 (A2A R) 这样的G蛋白合受体 (GPCR) 的药物位停留时间可以改善药物开发. 这项研究优化了A2A R纳米盘的稳定性,并描述了连接体结合动力学.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 结构生物学 结构生物学
背景情况:
- G蛋白结合受体 (GPCRs) 是关键的治疗点,但药物开发面临的挑战是体内疗效.
- 在体外药物点的停留时间 (1/koff) 是体内成功的有希望的预测指标.
- 氨酸A2A受体 (A2A R) 是一个关键的GPCR标.
研究的目的:
- 建立一种可靠的方法来确定A2A R. R. 的连接体结合动力学 (kon和koff).
- 为了优化纳米盘 (A2A R-NDs) 中净化A2A R的储存条件.
- 调查影响A2A R功能的因素,包括脂质,离子和质子.
主要方法:
- 基于光异性质的连接物结合测定.
- 将A2A R净化为纳米光盘 (A2A R-NDs).
- 在线费率 (kon) 和离线费率 (koff) 的动态分析.
主要成果:
- A2A R-NDs在 -80°C下表现出超过6个月的稳定性.
- 该试验成功地确定了kon和koff,用于与A2A R. R. 结合的配体.
- 获得了关于对A2A R的全调节的见解,以及带电脂和质子对激素结合的影响.
结论:
- 优化的A2A R-NDs为动力结合研究提供了一个稳定的系统.
- 联体结合动力学对于理解GPCR功能和改善药物发现至关重要.
- 这种方法提升了对GPCR标的体内药物疗效的预测.
相关概念视频
The Equilibrium Binding Constant and Binding Strength
12.8K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
12.8K
The Two-State Receptor Model
1.9K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
1.9K
Ligand Binding Sites
12.7K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.7K
Quantitative Aspects of Drug-Receptor Interaction
934
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
934
Drug-Receptor Interactions
4.9K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
4.9K
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K


